Edwards Lifesciences

Edwards Lifesciences's management team demonstrates strong execution, with stock-based compensation kept to just 2.4% of revenue. Consistent high returns on capital and stable operating margins indicate a team focused on operational excellence and long-term value creation rather than short-term metrics.